Article

Patient-derived lymphomoids preserve the tumor architecture and allow to assess response…

medRxiv · 2024 · Santamaria-Martinez, A.; Epiney, J.; Srivastava, D.; Tavernari, D.; Varrone, M.; Milowich, D.; Letovanec, I.; Krueger, T.; Duran, R.; Ciriello, G.; Cairoli, A.; Oricchio, E.

Key facts

Title Patient-derived lymphomoids preserve the tumor architecture and allow to assess response to therapies in lymphoma
First author Santamaria-Martinez, A.; Epiney, J.; Srivastava, D.; Tavernari, D.; Varrone, M.; Milowich, D.; Letovanec, I.; Krueger, T.; Duran, R.; Ciriello, G.; Cairoli, A.; Oricchio, E.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.04.15.589480
Devices mentioned K012371, K040782, K963139
Product codes mentioned DDD, DDG, JAK, MVU, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature